Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 FY- Text added to 2022 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
accessing, API, ATM, atonic, Becerra, benchmark, bid, billion, California, Catalyst, CCPA, Cerevel, Cir, consecutive, constantly, consummated, consummating, CTR, cutoff, cyberattack, DBP, dealing, discoloration, durable, easy, email, endeavor, excise, flow, FOS, GDP, graph, hindered, hypothetical, Kingdom, landscape, longstanding, main, managerial, military, misrepresentation, morale, Morgan, MPC, MRI, myasthenic, Needham, nil, OLE, opt, opted, paper, Pleasure, presidential, quickly, race, rapid, reconsider, recoup, recurring, religion, resurgence, reveal, rulemaking, Russia, score, SD, secondarily, serialization, sex, shortcoming, slower, staffing, striatum, Symptom, taxation, true, turnover, tying, Ukraine, undesirable, Unitary, unused, UPC, ventral, visibility, Wall, weekly, whichever, widespread
Removed:
accelerate, analyst, antiepileptic, approximate, belief, category, charter, child, codification, commitment, consolidate, covenant, delist, detected, detention, discourage, dispose, downgrade, emerge, FASB, formulated, function, gene, generating, GLP, GmbH, history, hydrogel, impair, inaccurate, inactive, inappropriate, incorporating, ineligible, institution, Irrespective, largest, long, Medpace, merge, Mine, negotiating, nerve, network, organizational, outsourced, package, partner, penny, pharmacodynamic, PIPEDA, preclude, projected, promptly, Qualitative, Quantitative, rank, redeem, release, repay, repeal, repurchase, reset, revocation, safeguarding, salary, scalable, senior, sublicensing, subordinated, sufficiency, sustainable, Teva, thermosensitive, toxicology, trailing, unsatisfactory, unsatisfied, venture, worked, Zogenix
Valuein 2021 FY filing- Value in 2022 FY filing
Original filings
Filing view